While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.
A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...
Moderna (MRNA) stock gained in the premarket after the company received a tender to supply its COVID-19 vaccine in the EU, ...
Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...
Under the resulting agreement, 17 participating countries can access Moderna's mRNA COVID-19 vaccine for up to four years. "This agreement presents an opportunity for Moderna to support and ...
The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain ...